Jpmorgan Chase & CO 908 Devices Inc. Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in 908 Devices Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 11,238 shares of MASS stock, worth $61,584. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,238
Previous 11,238
-0.0%
Holding current value
$61,584
Previous $98,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding MASS
# of Institutions
112Shares Held
24.7MCall Options Held
39.9KPut Options Held
13.6K-
Awm Investment Company, Inc. New York, NY5.2MShares$28.5 Million5.64% of portfolio
-
First Light Asset Management, LLC Edina, MN2.51MShares$13.8 Million2.64% of portfolio
-
State Street Corp Boston, MA2.3MShares$12.6 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.95MShares$10.7 Million0.12% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$9.28 Million0.0% of portfolio
About 908 Devices Inc.
- Ticker MASS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,590,200
- Market Cap $173M
- Description
- 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...